AAM releases 12th Annual Access & Savings Report
WASHINGTON — The Association for Accessible Medicines (AAM) has released the 2020 Access & Savings Report detailing the economic benefit of generic and biosimilar drugs to America’s patients. According to the report, the U.S. health care system saved $313 billion in 2019 from generics and biosimilar drugs, including $96 billion in Medicare savings and $48.5 billion in
